"Designing Growth Strategies is in our DNA"
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1 Prevalence of Key Cardiovascular Diseases- Key Countries, 2017
4.2 Health Reimbursement Scenario- Key Countries
4.3 Regulatory Scenario- Key Countries
4.4 Pricing Analysis
4.5 Recent Industry Developments - Partnerships, Mergers & Acquisitions
5. Global Cardiovascular Stents Market Analysis, Insights and Forecast,2014-2025
5.1. Key Findings/ Summary
5.2. Market Analysis, Insights and Forecast – By Procedure Type
5.2.1 Coronary Stenting
5.2.2 Peripheral Stenting
5.3. Market Analysis, Insights and Forecast – By Stent Type
5.3.1 Drug Eluting Stents (DES)
5.3.2 Bioresorbable Stents
5.3.3 Bare Metal Stents
5.3.4 Others
5.4 Market Analysis, Insights and Forecast – By Disease Indication
5.4.1 Venous Diseases
5.4.2 Arterial Diseases
5.5. Market Analysis, Insights and Forecast – By End User
5.5.1 Hospitals
5.5.2 Ambulatory Surgery Centers
5.5.3 Specialty Clinics
5.5.4 Catheterization Labs
5.6. Market Analysis, Insights and Forecast – By Region
5.6.1 North America
5.6.2 Europe
5.6.3 Asia Pacific
5.6.4 Latin America
5.6.5 Middle East & Africa
6.North America Cardiovascular Stents Market Analysis, Insights and Forecast,2014-2025
6.1. Key Findings/ Summary
6.2. Market Analysis, Insights and Forecast– By Procedure Type
6.2.1 Coronary Stenting
6.2.2 Peripheral Stenting
6.3. Market Analysis, Insights and Forecast – By Stent Type
6.3.1 Drug Eluting Stents (DES)
6.3.2 Bioresorbable Stents
6.3.3 Bare Metal Stents
6.3.4 Others
6.4. Market Analysis, Insights and Forecast – By Disease Indication
6.4.1 Venous Diseases
6.4.2 Arterial Diseases
6.5. Market Analysis, Insights and Forecast – By End User
6.5.1 Hospitals
6.5.2 Ambulatory Surgery Centers
6.5.3 Specialty Clinics
6.5.4 Catheterization Labs
6.6. Market Analysis, Insights and Forecast – By Country
6.6.1 U.S.
6.6.2Canada
7. Europe Cardiovascular Stents Market Analysis, Insights and Forecast, 2014-2025
7.1. Key Findings/ Summary
7.2. Market Analysis, Insights and Forecast – By Procedure Type
7.2.1 Coronary Stenting
7.2.2 Peripheral Stenting
7.3. Market Analysis, Insights and Forecast – By Stent Type
7.3.1 Drug Eluting Stents (DES)
7.3.2 Bioresorbable Stents
7.3.3 Bare Metal Stents
7.3.4 Others
7.4. Market Analysis, Insights and Forecast – By Disease Indication
7.4.1 Venous Diseases
7.4.2 Arterial Diseases
7.5. Market Analysis, Insights and Forecast – By End User
7.5.1 Hospitals
7.5.2 Ambulatory Surgery Centers
7.5.3 Specialty Clinics
7.5.4 Catheterization Labs
7.6.Market Analysis, Insights and Forecast – By Countries/Sub regions
7.6.1 Germany
7.6.2 U.K.
7.6.3 France
7.6.4 Italy
7.6.5 Spain
7.6.6 Scandinavia
7.6.7 Rest of Europe
8. Asia Pacific Cardiovascular Stents Market Analysis, Insights and Forecast,2014-2025
8.1. Key Findings/ Summary
8.2. Market Analysis, Insights and Forecast – By Procedure Type
8.2.1 Coronary Stenting
8.2.2Peripheral Stenting
8.3. Market Analysis, Insights and Forecast – By Stent Type
8.3.1 Drug Eluting Stents (DES)
8.3.2 Bioresorbable Stents
8.3.3 Bare Metal Stents
8.3.4 Others
8.4. Market Analysis, Insights and Forecast – By Disease Indication
8.4.1 Venous Diseases
8.4.2 Arterial Diseases
8.5. Market Analysis, Insights and Forecast – By End User
8.5.1 Hospitals
8.5.2 Ambulatory Surgery Centers
8.5.3 Specialty Clinics
8.5.4 Catheterization Labs
8.6. Market Analysis, Insights and Forecast – By Countries/Sub regions
8.6.1 China
8.6.2 India
8.6.3 Japan
8.6.4 Australia
8.6.5 Southeast Asia
8.6.6 Rest of Asia Pacific
9.Latin America Cardiovascular Stents Market Analysis, Insights and Forecast,2014-2025
9.1. Key Findings/ Summary
9.2. Market Analysis, Insights and Forecast – By Procedure Type
9.2.1 Coronary Stenting
9.2.2 Peripheral Stenting
9.3. Market Analysis, Insights and Forecast – By Stent Type
9.3.1 Drug Eluting Stents (DES)
9.3.2 Bioresorbable Stents
9.3.3 Bare Metal Stents
9.3.4 Others
9.4. Market Analysis, Insights and Forecast – By Disease Indication
9.4.1 Venous Diseases
9.4.2 Arterial Diseases
9.5. Market Analysis, Insights and Forecast – By End User
9.5.1 Hospitals
9.5.2 Ambulatory Surgery Centers
9.5.3 Specialty Clinics
9.5.4 Catheterization Labs
9.6. Market Analysis, Insights and Forecast – By Countries/Sub regions
9.6.1 Mexico
9.6.2 Brazil
9.6.3Rest of Latin America
10. Middle East & Africa Cardiovascular Stents Market Analysis, Insights andForecast, 2014-2025
10.1. Key Findings/ Summary
10.2. Market Analysis, Insights and Forecast – By Procedure Type
10.2.1 Coronary Stenting
10.2.2 Peripheral Stenting
10.3. Market Analysis, Insights and Forecast – By Stent Type
10.3.1 Drug Eluting Stents (DES)
10.3.2 Bioresorbable Stents
10.3.3 Bare Metal Stents
10.3.4 Others
10.4. Market Analysis, Insights and Forecast – By Disease Indication
10.4.1 Venous Diseases
10.4.2 Arterial Diseases
10.5. Market Analysis, Insights and Forecast – By End User
10.5.1 Hospitals
10.5.2 Ambulatory Surgery Centers
10.5.3 Specialty Clinics
10.5.4 Catheterization Labs
10.6. Market Analysis, Insights and Forecast – By Countries/Sub regions
10.6.1 GCC
10.6.2 South Africa
10.6.3 Rest of Middle East & Africa
11. Competitive Analysis
11.1. Key Industry Developments
11.2. Global Market Share Analysis (2017)
11.3. Competition Dashboard
11.4. Comparative Analysis – Major Players
11.5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
11.5.1 Biotronik SE & Co. KG
11.5.2 Cardinal Health
11.5.3 Cook
11.5.4 C. R. Bard, Inc.
11.5.5 MicroPort Scientific Corporation
11.5.6 Terumo Corporation
11.5.7 B. Braun Melsungen AG
11.5.8 Abbott
11.5.9 Boston Scientific Corporation
11.5.10 Medtronic
11.5.11 Other Prominent Players
12.Strategic Recommendations
Related Reports